Podcasts about Childhood cancer

Donations made through the "More Than 4 Challenge" go directly toward funding research and raising awareness for childhood cancer — a cause that receives only 4% of federal cancer research funding despite being the leading cause of disease-related death among children. https://www.pledge.to/mt4zoesgoal with $4 donation. Zoe's Goal City: Beverly Hills Address: 133 N Almont Dr, #301 Website: https://zoesgoal.org/ Phone: +1 602 487 1546 Email: leslie@zoesgoal.org

There are some conversations that stay with you long after the recording ends, and this was one of them. When I first came across Brady Lucas and heard pieces of his story, I immediately knew I wanted him on the podcast. As a cancer mom myself, hearing from survivors who are now thriving years later brings so much hope — not just for me, but for every family walking through this journey right now. Brady was diagnosed with acute lymphoblastic leukemia at just 8 years old. After enduring years of chemotherapy, he relapsed as a teenager and underwent a life-saving bone marrow transplant donated by his younger brother. In this conversation, he shares what it was like to face cancer as a child, the emotional weight survivors carry long after treatment ends, and how his perspective on health completely transformed because of it. We also talk about something I'm incredibly passionate about: what happens after treatment. Because surviving cancer is not the finish line. It's the beginning of rebuilding the body, supporting long-term healing, and creating an environment where health can truly thrive. Brady shares how nutrition, movement, sleep, emotional healing, and community support became foundational parts of his healing journey — and why he now feels called to educate and empower other families. This episode is honest, emotional, encouraging, and deeply hopeful. If you are in the middle of treatment, supporting someone you love through cancer, or navigating survivorship yourself, I hope Brady's story reminds you that there is life, purpose, healing, and hope on the other side of this.   Guest Links Website: bradylucasauthor.com Instagram: @bradyluu LinkedIn: bradychristopherlucas X (Twitter): @bradyluu Book on Amazon: https://www.amazon.com/Smileys-Smile-Brady-Lucas/dp/1633086674 Recommended Tools & Resources LumeBox: https://bit.ly/seasonjohnsonlume Use code seasonjohnson for $260 off Community & Support Join Thrive Through Cancer Community: https://biodynamicwellness.com/services Connect with Season Website: www.seasonjohnson.com Instagram: @seasonjohnson  

Why is pediatric brain cancer research so underfunded, and what does it actually take to build breakthroughs for children fighting cancer?In this episode of Game Over: c*ncer, Val Solomon and Dana Nichols sit down with Dr. John Prensner, pediatric neuro-oncologist, researcher, and Assistant Professor of Pediatrics at the University of Michigan Medical School. As the recipient of the 2025 Young Investigator Grant from Cannonball Kids' cancer Foundation, Dr. Prensner is leading groundbreaking research focused on relapsed medulloblastoma, DIPG, ATRT, and the molecular drivers behind pediatric brain tumors.Dr. Prensner shares the deeply personal story that inspired him to pursue pediatric cancer research after encountering a young mother dying of brain cancer during his early hospital experiences. The conversation explores the emotional realities of pediatric oncology, the importance of mentorship in science, and how collaboration between labs, institutions, and researchers across the world is accelerating innovation for children with cancer.This episode also dives into the growing concerns surrounding pediatric cancer funding, NIH research grants, instability in federal funding, and the long-term effects these challenges have on the future pipeline of childhood cancer researchers and scientific breakthroughs.If you care about advancing pediatric cancer research, supporting innovative treatments, and learning how researchers are working to change outcomes for children battling cancer, this episode is for you.----------------------------------Connect with Dana: https://www.linkedin.com/in/danaknichols/Connect with Val: https://www.linkedin.com/in/valerie-solomon/Upcoming Ckc Events: https://cannonballkidscancer.org/category/make-an-impact/events/----------------------------------Podcast Produced by Hi Hello Labs: Website: https://www.hihellolabs.com/

Put down the "Standard of Care" manual for a second, this week I'm talking to you like a med student watching a corporate train wreck in slow motion as we break down the "rigged" request for proposals (RFP) process. I'll show you how a local group with 35 years of perfect staffing was given a "0.1" score for call coverage just so a corporate giant could swoop in. We'll also discuss a federal judge's incredible "low-wattage" insult and why two Apollo MD doctors are now facing accusations of lying under oath. After we finish our lesson on corporate retaliation, we're pivoting to some "legitimate" science that sounds like a skit: Pig Semen Eye Drops. I'll explain a recent study, yes, in an actual scientific journal, about using exomes from pig semen to shrink retinoblastoma tumors in mice by 98%. It's a perfect confluence of my two professional loves: medicine and comedy. Takeaways: The "Rigged" Scorecard: How Eugene Emergency Physicians were given a near-zero score for "transition planning" despite already being the ones doing the job. The MSO Loophole: Why companies like Apollo MD create "shell" clinical entities to circumvent state laws meant to protect local medicine. The Judge's Admonishment: Why "evasive" testimony and "obfuscation" led a federal judge to suggest that corporate executives were lying under oath. The "Rodent" Breakthrough: How a basic science study used pig semen to reduce rare childhood eye tumors to just 2% of their original size. Aged Urine vs. Science: Why the new retinoblastoma research is a major step up from the "aged urine" eye drop groups Will fought as a resident. To Get Tickets to Wife & Death: You can visit Glaucomflecken.com/live  We want to hear YOUR stories (and medical puns)! Shoot us an email and say hi! knockknockhi@human-content.com Can't get enough of us? Shucks. You can support the show on Patreon for early episode access, exclusive bonus shows, livestream hangouts, and much more! –⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ http://www.patreon.com/glaucomflecken⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  Also, be sure to check out the newsletter: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://glaucomflecken.com/glauc-to-me/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ If you are interested in buying a book from one of our guests, check them all out here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.amazon.com/shop/dr.glaucomflecken⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ If you want more information on models I use: Anatomy Warehouse provides for the best, crafting custom anatomical products, medical simulation kits and presentation models that create a lasting educational impact.  For more information go to Anatomy Warehouse DOT com. Link: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://anatomywarehouse.com/?aff=14⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Plus for 15% off use code: Glaucomflecken15 -- A friendly reminder from the G's and Tarsus: If you want to learn more about Demodex Blepharitis, making an appointment with your eye doctor for an eyelid exam can help you know for sure. Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.EyelidCheck.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ for more information.  Produced by⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Human Content⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, I sit down with Roxy and her mom, Diana, to share a story that is both deeply emotional and incredibly hope-filled. Roxy was just four years old when her family discovered a lump that would quickly turn their world upside down. From diagnosis to treatment, and then facing a relapse scare, Diana shares what it was like to walk through fear, uncertainty, and the weight of life-altering decisions as a parent. But what unfolds in this conversation is something even more powerful—a story of faith, resilience, and the unwavering belief in healing. From Roxy's childlike confidence in her healing, to the intentional choices their family made to support her body, this episode is a reminder of the strength that can be found in both faith and action. LINKS: Join Thrive Through Cancer Community: https://biodynamicwellness.com/services Follow us on Instagram: @BiodynamicWellness Learn about our Thrive Through & Beyond Cancer Programs: biodynamicwellness.com/thrive-through-cancer and biodynamicwellness.com/thrive-beyond-cancer Follow Season on Instagram: @seasonjohnson Learn more: www.seasonjohnson.com Diana (Roxy's Mom) Instagram:  instagram.com/samkodiana

In this deeply personal episode, Casey sits down with AJ's father, Ricky De La Torre, to honor the life and memory of his son. Together, they reflect on the moments that mattered most—the laughter, the strength, and the unbreakable bond they shared as a family. Ricky opens up about the long days and sleepless nights spent in and around hospital walls, waiting, hoping, and holding on during an incredibly difficult time, especially through the isolation of the COVID shutdown.But this isn just a story of loss—it's a story of love, resilience, and the kind of courage that leaves a lasting mark on everyone it touches.Brain cancer continues to impact far too many children and families each year. By listening, you're already helping share AJ's story—but you can take it one step further. At the end of this episode, you'll hear about foundations that are working to make a difference. We invite you to stand with Ricky, honor AJ's memory, and consider giving whatever you can. No amount is too small when it comes to creating hope. May the 4th be with you!Thank you for listening, for caring, and for being part of something bigger.Rickys Instagram: @dads_in_the_fightAJ's Instagram: @prayers_for_ajCasey's Instagram: @real_casey_diaz_Jacob Diaz Instagram: @_jacobdiaz_To donate to this podcast:Zelle:antiochburbank@gmail.com*Please write on note - The Shot Caller Podcast#podcasting #cancersucks #braincancer #cancerstory

Talking about Dicky Hiley St Jude Bass Classic, having guests, telling stories and raising money while giving away great fishing prizes!eBay Auctions for St Jude - https://ebay.us/fL9xCESt Jude Fundraising Page - https://fundraising.stjude.org/site/TR?px=8738254&fr_id=161555&pg=personal

“You're not broken… you're becoming.”  ~Tom SnyirIn this second half of our conversation, Tom and Heather Snyir share what life has looked like in the days, months, and years since their daughter Katie Rae went to Heaven.We talk about the realities of everyday grief - navigating the things people say, learning to live with “grief brain,” and facing simple questions that suddenly feel anything but simple.Tom and Heather also reflect on how grief has changed them - how it's reshaped their perspective, their relationships, and the way they move through the world.Tom opens up about his personal journey with PTSD, depression, and suicidal thoughts, and the people and faith that helped carry him through. He also shares about his devotional book, Branches of Grace, and the message of hope it offers to those walking through trauma and loss.This conversation is honest, practical, and full of insight for anyone navigating life after the loss of a child.Key Takeaways Presence matters more than words when supporting someone in grief  You are allowed to set boundaries and protect your heart  Grief changes you ... and that doesn't mean something is wrong  You don't have to walk through dark seasons alone  Healing and pain can exist side by side Resources & MentionsTom's book: Branches of Grace: Devotions from the Front Lines of Faith is available on Amazon.  Click HERE to find it.  Suicide & Crisis Lifeline (U.S.): Call or text 988I would love to hear your thoughts on the show. Click here to send me a message! (Though I read every message, I am unable to respond through this format.) ** IMPORTANT** - All views expressed by guests on this podcast are theirs alone, and may not represent the Statement of Faith and Statement of Beliefs of the While We're Waiting ministry.  We'd love for you to connect with us here at While We're Waiting! Click HERE to visit our website and learn about our free While We're Waiting Weekends for bereaved parentsClick HERE to learn more about our network of While We're Waiting support groups all across the country. Click HERE to subscribe to our YouTube channelClick HERE to follow our public Facebook pageClick HERE to follow us on Instagram Click HERE to follow us on Twitter Click HERE to make a tax-deductible donation to the While We're Waiting ministryContact Jill by email at:  jill@whilewerewaiting.org 

In this week's episode, host Latisha Guinn talks with Chris Eckstein about what it looks like to turn personal passion into meaningful impact and talks about his support for childhood cancer research through the St. Baldrick's Foundation. Each year, Chris goes all in, raising funds, rallying support, and even dyeing (and ultimately shaving) his hair to bring awareness to the cause. But behind the bold look is a powerful story of purpose, community, and commitment. Join us as we talk about what inspires Chris, how he mobilizes others, and why giving back is more than just a moment—it's a mindset.And a special shout-out to Main Street Barbers in Carmel, IN, for volunteering their services to cut participants' hair every year.Watch the Video Version:https://youtu.be/p3KBYpDmcEswww.stbaldricks.org #ASCIIAnything #MoserConsulting #GiveBack #Leadership #CommunityImpact #StBaldricks #Podcast #InformationTechnology #technology

Send us Fan MailThank you, Steve Garraty, for making today's episode possible!Our next guest beat leukemia as a kid, got cut from a football team that “doesn't cut anyone,” and still grew up believing the hard thing wasn't a sign to quit, it was proof he was built for it. That's why this conversation with Bishoy Tadros hits so deep for anyone thinking about fatherhood, resilience, and what it really means to lead at home.  Bishoy is the author of two acclaimed books—Break Barriers: How Setbacks Can Dare You Rather Than Define You and Audacious: Uncaging Your Authentic Self—and the creator and host of the Mile 40 Podcast. Mile 40 has quickly become a standout in the health, wellness, and personal growth space, known for its compelling interviews with athletes, entrepreneurs, and thought leaders who have turned adversity into opportunity.  He is also a very talented Sr. Account Executive for SalesForce.We talk about his family's immigrant journey from Egypt to the United States for treatment, and the three values his parents modeled through action: patience, perspective, and purpose. Bishoy explains how his dad, a Coptic Orthodox priest, served a community with calm consistency without forcing religion on anyone, and how that example shaped how he shows up as a husband and a dad. We also get honest about a modern parenting challenge: how do you teach empathy, selflessness, and healthy struggle when your kids grow up with more comfort than you did?Then the story pivots to the moment that gave Beshoy's own podcast its name. After reaching Wall Street and realizing achievement didn't equal fulfillment, he chased a long-buried athletic identity and trained for an Ironman 70.3. At mile 40, dehydrated and ready to quit, he used one simple tool to finish: celebrate small wins, one mile at a time. That mindset helped him run marathons, raise serious money for charity, and become the first Egyptian to complete all seven World Marathon Majors.If you care about parenting, mindset, endurance, and values-based leadership, you'll want to hear this one. Subscribe, share it with a dad who needs a boost, and leave us a review so more people can find the show.Support the showPlease don't forget to leave us a review wherever you consume your podcasts!  Please help us get more dads to listen weekly and become the ultimate leader of their homes! 

"God doesn't always remove the suffering—He enters into it with us.” In this first half of our conversation, Tom and Heather Snyir share the story of their daughter, Katie Rae—a creative, joyful teenager who made everyone around her feel like they were her best friend.Katie was diagnosed with leukemia at just four years old.  Tom and Heather share what it was like to navigate months of treatment, a bone marrow transplant, and the gift of more than a decade of remission.Then, as a teenager, Katie was diagnosed with glioblastoma, an aggressive and deadly form of brain cancer. In this episode, Tom and Heather begin sharing what that journey looked like for their family and how they walked through those difficult days together until Katie went to Heaven.Throughout this conversation, you'll hear how their faith was stretched and sustained—not through easy answers, but through God's presence in the middle of uncertainty.Resources & Mentions Tom Snyir's book: Branches of Grace: Devotions from the Front Lines of Faith - Available HERE.  Coming NextIn next week's episode, Tom and Heather share what life has looked like since Katie went to Heaven. We talk about grief in everyday life, how people respond to loss, and Tom shares more of his personal journey through PTSD, depression, and finding hope.I would love to hear your thoughts on the show. Click here to send me a message! (Though I read every message, I am unable to respond through this format.) ** IMPORTANT** - All views expressed by guests on this podcast are theirs alone, and may not represent the Statement of Faith and Statement of Beliefs of the While We're Waiting ministry.  We'd love for you to connect with us here at While We're Waiting! Click HERE to visit our website and learn about our free While We're Waiting Weekends for bereaved parentsClick HERE to learn more about our network of While We're Waiting support groups all across the country. Click HERE to subscribe to our YouTube channelClick HERE to follow our public Facebook pageClick HERE to follow us on Instagram Click HERE to follow us on Twitter Click HERE to make a tax-deductible donation to the While We're Waiting ministryContact Jill by email at:  jill@whilewerewaiting.org 

The Rao Lab at Seattle Children's Research Institute developed a three-dimensional (3D) tissue-engineered model of osteosarcoma to investigate the effects of the extracellular matrix on malignant cell function. The study demonstrated that culturing osteosarcoma (OS) cells within a 3D collagen matrix induced unique cellular responses, altered morphology, enhanced tumorigenic behavior, and reduced chemosensitivity compared to cells cultured in 2D collagen or on standard tissue culture plastic. They identified overexpression of drug efflux pumps as a key mechanism of chemoresistance and further showed that a tyrosine kinase inhibitor could suppress drug efflux activity, thereby enhancing the efficacy of standard chemotherapeutic agents.While this earlier study examined the effects of a single collagen concentration on osteosarcoma phenotype, clinical solid tumors are characterized by altered extracellular microarchitecture, including increased matrix density and stiffness. These changes restrict drug transport and limit chemotherapy-induced cell death.Dr. Rao will present findings from engineered tumor models incorporating varying matrix densities and demonstrate how matrix density influences osteosarcoma function. This work was funded by the 2025 Outsmarting Osteosarcoma Young Investigator Hope Award.Dr. Rao is a Pediatric Hematologist Oncologist at the Seattle Children's Hospital and a Principal Investigator in the Ben Towne Center for Childhood Cancer and Blood Disorders Research at the Seattle Children's Research Institute. His lab harnesses biomaterials and tissue engineering technologies to design 3D models of osteosarcoma to understand how cell-matrix interactions lead to chemoresistance.

In this powerful episode of Game Over: c*ncer, hosts Dana and Val sit down with Dr. Kira Bona, pediatric oncologist at Dana-Farber/Boston Children's Hospital and associate professor at Harvard Medical School, to explore a critical but often overlooked issue in pediatric cancer care: access and health equity.Dr. Bona shares groundbreaking research revealing that one in three children diagnosed with cancer lives in a household facing poverty-related challenges, such as food insecurity, housing instability, or lack of transportation. Even when children receive treatment at top hospitals and participate in clinical trials, these social factors can still impact survival outcomes.Together, they unpack how social determinants of health influence treatment success, why traditional support systems may not be enough, and what researchers are doing to create health equity interventions that improve outcomes for children and families facing financial hardship.This conversation highlights the intersection of oncology and public health, offering hope for a future where every child fighting cancer has an equal chance to survive and thrive.Support the Ignite Consortium: https://igniteconsortium.org----------------------------------Connect with Dana: https://www.linkedin.com/in/danaknichols/Connect with Val: https://www.linkedin.com/in/valerie-solomon/Upcoming Ckc Events: https://cannonballkidscancer.org/category/make-an-impact/events/----------------------------------Podcast Produced by Hi Hello Labs: Website: https://www.hihellolabs.com/

Dedicated to Mary Elizabeth.  Amanda “Mandi” Posey Paris and Alix Flannigan Hunsucker, both Georgia, pledge sisters and best friends from Alpha Rho Chapter, have walked through the unthinkable together, facing Mandi's daughter's cancer battle, fear and loss. Today, as they build Mandi Paris Designs—their thriving brand of original art turned luxury fabric, wallpaper and fashion—Mary Elizabeth's memory is woven into everything Mandi creates. Her strength, joy and fight live on in every pattern, risk and dream pursued.  In this episode, you'll hear what their experience with St. Jude Children's Research Hospital was really like, how Tri Delta continues to shape their lives and why advocating for cancer research is deeply personal. The conversation is heartbreaking, funny, deeply inspirational and by the end, you'll fall in love with these two women. Most of all, you'll witness what it looks like when two friends decide they will never walk alone. And you'll believe that strength, love and purpose truly outlive loss.

When Megan Gilmour's son was 10 years old, he spent nearly two years in isolation at the Sydney Children's Hospital. The months he missed at school didn't just affect him academically. Megan, her daughter and her husband all relocated from Canberra to be with Darcy in Sydney as he underwent life-saving medical treatment, and lived at hospital.Over his many months in hospital, Darcy missed a lot of school. What worried Megan wasn't just that he was falling behind academically, it was his loneliness and the way he was losing connection to his friends and his community.Over time Megan watched how Darcy's sense of belonging vanished because he wasn't physically at school.So along with two other mums she met through the Sydney Children's Hospital, Megan decided to do something about it.Not just for the kids who are missing out of school because they are in hospital, but for the growing number of kids who are away from school for a whole host of reasons.Megan is the CEO and co-founder of Missing School, and she was the 2025 ACT Australian of the Year.This episode of Conversations was produced by Meggie Morris. Executive Producer is Nicola Harrison.It explores chronic illness, sick kids, school non attendance, school refusal, my kid doesn't want to go to school, young carers, neurodiverse children, autism, ADHD, AuDHD, learning difficulties, childhood cancer, blood disorders, lonely children, invisible siblings, parenting, motherhood, online learning, COVID, digital schooling, bone marrow transplant.To binge even more great episodes of the Conversations podcast with Richard Fidler and Sarah Kanowski go the ABC listen app (Australia) or wherever you get your podcasts. There you'll find hundreds of the best thought-provoking interviews with authors, writers, artists, politicians, psychologists, musicians, and celebrities.

Join PeDRA Fellow Hannah Chang for a roundtable discussion with special guests Dr. Jillian Rork and Dr. Deepti Gupta. Together, they discuss a recent publication titled “Impact of Persistent Alopecia on Quality of Life in Childhood Cancer and Transplant Survivors.” This article was published in Pediatric Blood & Cancer in 2025.

Tveen Verano shares her family's emotional journey from a joyful, ordinary life to the shock of a childhood cancer diagnosis. Her story highlights the power of faith, community, and the importance of spiritual resilience amid unimaginable hardships. Main Topics Covered:The emotional impact of childhood cancer diagnosis and treatmentHow faith and scripture sustain families during crisesPractical ways to support loved ones in their struggleThe role of community and prayer in healing and hopeBalancing joy and grief in the midst of sufferingIn this episode:Tveen recounts her son Alex's diagnosis and initial shockThe importance of faith and Scripture, especially Psalm 16:8The emotional and spiritual processing during crisis momentsThe significance of community support, prayer, and a positive mindsetNavigating sibling reactions and family dynamicsHope and remissionAdvice for supporting others facing illnessThe importance of balanced support groups and spiritual formationResources & Links:Psalm 16:8Don't Give the Enemy a Seat at Your Table by Louis GiglioUnmet Expectations by Lisa HughesBroken and Mended support group ministryNeuroblastoma InformationEpisode w/Lara SilvermanConnect with Tveen Verano:https://www.instagram.com/tveenverano.rd/https://www.youtube.com/@tveenverano9283Thank you for listening. Join us next time on In the Seams for more stories of faith, perseverance, and hope.Host: David HeflinProducer: Andres RuizEditor: John Shields

February 20, 2026 ~ Lloyd Jackson and Jamie Edmonds speak with Roy Townsend about 13Forever. The charity is holding their Bag Childhood Cancer Cornhole event on Saturday the 21st at Great Shots Backyard Bar and Games in Clinton Township that will feature DJs, raffles and other fun things to raise money for childhood cancer research. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

SEND US FAN MAILChildhood cancer survival rates differ dramatically worldwide. In this episode of the Spartan Nurse Podcast, Courtney Sullivan, assistant professor and global pediatric oncology nurse scientist at the Michigan State University College of Nursing, discusses quality indicators, safe chemotherapy delivery, nurse safety, and how global health initiatives are working to reduce survival disparities.Topics include pediatric oncology nursing, childhood cancer care, global survival inequities, nursing research, workforce development, and the World Health Organization's Global Initiative for Childhood Cancer.Learn more about the Michigan State University College of Nursing:https://nursing.msu.eduTo find your breaking news and latest updates within the College of Nursing, please refer to our website at nursing.msu.edu. You can also find us on all social media platforms @MICHSTNursingIf you have a question for our hosts or a prospective guest, please message us at: MCOM.nursing@msu.edu

Good morning—buenos días ☕️

The Leukemia Foundation is warning more than 400 children a year could face a blood cancer diagnosis within the next decade. The foundation is attempting to raise $12 million through its annual World's Greatest Shave campaign, with funds contributing to research and support services to families impacted by blood cancer. - ትካል 'ሊዩከሚያ ፋውንዴሽን' ልዕሊ 400 ህጻናት ኣብ ዓመት ኣብ ውሽጢ'ዚ ዝመጽእ ዘሎ ዕቑድ ሕማም መንሽሮ ወይ ካንሰር ደም ከጋጥሞም ከምዝኽእል የጠንቅቕ። እቲ ትካል ብመንገዲ'ቲ ዓመታዊ ዘካይዶ ጎስጓስ ምልጻይ ጸጒሪ (greatest shave campaign) ኣቢሉ $12 ሚልዮን ዶላር ክእክብ ይፍትን ኣሎ፡ እቲ ዝእከብ ሓገዝ ድማ ናብ ምርምራትን ብካንሰር ደም ዝተጸልዉ ስድራቤታት ኣገልግሎት ድጋፍ ዝረኽብሉን ኣበርክቶ ክገብር'ዩ።

The Leukemia Foundation is warning more than 400 children a year could face a blood cancer diagnosis within the next decade. The foundation is attempting to raise $12 million through its annual World's Greatest Shave campaign, with funds contributing to research and support services to families impacted by blood cancer.

Donyshia Boston-Hill gets business empowerment from Terrie Magro, co-founder of the Michael Magro Foundation, advocates for children and families affected by childhood cancer.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Vascular Health and Early Atherosclerosis in Childhood Cancer Survivors: Reassuring Findings From Comprehensive Noninvasive Assessment.

In this episode, Adam Torres and Majed Mohamed, Head of Community Engagement & Advocacy at Friends of Cancer Patients, talk about reducing stigma, improving early cancer detection, and advancing patient-centered advocacy through awareness, policy engagement, and direct support initiatives in the UAE. About Majed Mohamed A passionate and dedicated Public Health Specialist with a strong foundation in medical sciences, committed to improving health outcomes through strategic advocacy, policy development, and research. Experienced in working across sectors to promote awareness, prevention, and support for patients with NCDs. Focused on enhancing healthcare systems, driving public health initiatives, and contributing to global efforts to improve cancer care. Specializing in patient advocacy, health policy, and research, with a keen interest in fostering partnerships between public and private sectors to create impactful solutions for pressing health challenges. About Friends of Cancer Patients Friends of Cancer Patients charity is a non-profit organization registered at the UAE Ministry of Social Affairs under the ministerial decree No. 427 for the year 2013. FOCP was founded in September 1999 under the directives and patronage of Her Highness Sheikha Jawaher bint Mohammed Al Qasimi, Wife of the Ruler of Sharjah, International Ambassador of the World Cancer Declaration for Union for International Cancer Control (UICC) and International Ambassador for Childhood Cancer for UICC and Founder and Patron of the Friends of Cancer Patients society. Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule. Apply to be a guest on our podcast: https://missionmatters.lpages.co/podcastguest/ Visit our website: https://missionmatters.com/ More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode, ⁠Adam Torres⁠ and ⁠Majed Mohamed⁠, Head of Community Engagement & Advocacy at Friends of Cancer Patients, talk about reducing stigma, improving early cancer detection, and advancing patient-centered advocacy through awareness, policy engagement, and direct support initiatives in the UAE. About ⁠Majed Mohamed⁠ A passionate and dedicated Public Health Specialist with a strong foundation in medical sciences, committed to improving health outcomes through strategic advocacy, policy development, and research. Experienced in working across sectors to promote awareness, prevention, and support for patients with NCDs. Focused on enhancing healthcare systems, driving public health initiatives, and contributing to global efforts to improve cancer care. Specializing in patient advocacy, health policy, and research, with a keen interest in fostering partnerships between public and private sectors to create impactful solutions for pressing health challenges. About ⁠Friends of Cancer Patients⁠ Friends of Cancer Patients charity is a non-profit organization registered at the UAE Ministry of Social Affairs under the ministerial decree No. 427 for the year 2013. FOCP was founded in September 1999 under the directives and patronage of Her Highness Sheikha Jawaher bint Mohammed Al Qasimi, Wife of the Ruler of Sharjah, International Ambassador of the World Cancer Declaration for Union for International Cancer Control (UICC) and International Ambassador for Childhood Cancer for UICC and Founder and Patron of the Friends of Cancer Patients society. Follow Adam on Instagram at ⁠https://www.instagram.com/askadamtorres/⁠ for up to date information on book releases and tour schedule. Apply to be a guest on our podcast: ⁠https://missionmatters.lpages.co/podcastguest/⁠ Visit our website: ⁠https://missionmatters.com/⁠ More FREE content from Mission Matters here: ⁠https://linktr.ee/missionmattersmedia⁠ Learn more about your ad choices. Visit podcastchoices.com/adchoices

Rob Hirst, the former drummer for the band Midnight Oil has died at age 70. In 2018 Sarah sat down with Rob for a wide-ranging conversation about music, nature and reconnecting with family (R)

Dr. Craig Mullen joins us to discuss how we can continue to see the mercy of God, even when children suffer the horrors of cancer. Father finishes with Timely Thoughts.  Show Notes Childhood Cancer and the Problem of Evil - The Society of Catholic Scientists  Why didn't God heal Mom?  The Problem of Evil: The Aquinas Lecture by Errol Harris Saint Thomas and the Problem of Evil (Aquinas Lecture 6) - Jacques Maritain Psalms and Compassions: A Jesuit's Journey Through Cancer When a Kid Like Me Fights Cancer What Happens When My Sibling Has Cancer: A Book for the Brothers and Sisters of Pediatric Cancer Patients): Olsher, Sara Support4Families for Children & Parents | Crossroads4Hope Support Networks for Parents of a Child with Cancer - Together by St. Jude™ The Problem of Pain: Lewis, C. S. PDQ® Cancer Information - NCI iCatholic Mobile The Station of the Cross Merchandise - Use Coupon Code 14STATIONS for 10% off | Catholic to the Max Read Fr. McTeigue's Written Works! "Let's Take A Closer Look" with Fr. Robert McTeigue, S.J. | Full Series Playlist Listen to Fr. McTeigue's Preaching! | Herald of the Gospel Sermons Podcast on Spotify Visit Fr. McTeigue's Website | Herald of the Gospel Questions? Comments? Feedback? Ask Father!  

In this episode of the Believe Big Podcast, Ivelisse sits down with Dr. Michelle Niesley, a recognized leader in integrative oncology, to explore pediatric cancer care through a whole-person lens. They dive into the importance of sleep, nutrition, and addressing environmental factors, while also discussing how integrative therapies like mistletoe can complement conventional treatments. Dr. Niesley shares insights on the role of functional medicine, the emotional toll of a diagnosis, and how families can effectively support their children through treatment. This conversation offers practical guidance, hope, and a vision for a more collaborative approach to pediatric cancer care and survivorship.Learn more ABOUT Dr. NiesleySuggested ResourcesChemo and CrayonsBLOG - Chemo and CrayonsRESOURCES - Chemo and CrayonsRiordan Clinic WebsitePODCAST - Real HealthSend us Fan Mail! Click here >Your donations power our podcast's mission to support cancer patients with hope, insights, and resources. Every contribution fuels our ability to uplift and empower. Join us in making a lasting impact. Donate now!

This episode is another very personal one. My son eight year old son William was diagnosed with medulloblastoma nearly a year ago. He's since on embarked on an incredible journey of brain surgery, radiation, and chemotherapy – and recently rang the bell completing his treatment right before Thanksgiving.His response to this adversity has been nothing short of amazing and awe-inspiring. His smile and laughter has never ceased, his poise and strength are well-beyond his years, and I've chronicled his story on LinkedIn – where you'll see his incredible strength and optimism on display. Along the way, I've met some incredible people and world changers. One of those world changers is Dr. Jim Olson from Seattle Children's. James M. Olson, MD, PhD, is program director for the Invent at Seattle Children's Postdoctoral Scholars Program, a principal investigator in the Ben Towne Center for Childhood Cancer and Blood Disorders Research, and a professor at the University of Washington School of Medicine. He co-founded three biotechnology companies and has mentored more than 30 graduate students and postdoctoral research fellows. He chaired a national phase III clinical trial for high-risk medulloblastoma patients that led to a 20% improvement in five-year survival for Group 3 patients. Dr. Olson is the principal investigator on multiple projects that focus on developing effective new therapies for pediatric brain tumors; methods that allow surgeons to better visualize the border of brain cancer and normal brain, and the discovery of immunotherapeutics for several cancers. Dr. Olson's game changing research in immunotherapy could potentially revolutionize the standard of care as we know it – and has the potential to replace radiation and chemotherapy. In lab trials, this treatment completely eliminated cancer in 90% of brain tumors that are otherwise universally fatal in children. Mice that received the treatment were alive and disease-free, while the untreated mice died within 18 days.In this podcast, we discuss his research, next steps for funding and clinical trials – and what this could mean for families moving forward. Please enjoy this conversation and donate to Dr. Olson's groundbreaking immunotherapy trial here.

Ryan Sternagel—co-founder of The Stern Method, Going Integrative Plus (GIP+), and Our Health Naturally—joins Dr. Karlfeldt to share the real story behind his family's mission: in 2014, Ryan and his wife Teddy learned their son Ryder had stage four neuroblastoma just eleven days before his first birthday. What followed was a crash course in advocacy, research, and resilience—plus a decades-worth of integrative insights earned the hard way. If you've ever felt overwhelmed by a diagnosis, pressured into one path, or unsure how to “do everything” without losing your mind, this conversation is for you.In this episode, Ryan walks through the moment they knew something was wrong, the medical runaround that nearly delayed answers, and how they learned to push for imaging, ask better questions, and make decisions strategically—especially when facing institutional pressure. They discuss the chess match many families experience in pediatric oncology, including navigating treatment expectations, scan decisions, and the importance of building a supportive plan that addresses nutrition, environment, and mindset alongside medical care. Ryan also shares the evolution from documenting their journey online to creating a searchable library of expert integrative oncology guidance through GIP+—so families can learn directly from top holistic cancer doctors and “test-drive” approaches that resonate.You'll also hear Ryan's perspective on “cake vs. frosting”: why foundational daily practices (circadian rhythm, nature time, reducing toxic load, nervous system regulation, and belief/mindset work) often matter more than any shiny new therapy—yet how select advanced tools may fit into a larger integrative strategy. This is a grounded, motivating listen for patients, caregivers, and practitioners who want a more empowered, organized way forward.Key Topics CoveredRyder's stage 4 neuroblastoma diagnosis and the early warning signs that were missedSelf-advocacy in pediatrics: pushing for ultrasound/MRI and trusting intuitionNavigating hospital systems, treatment escalation, and the realities of compliance pressureBuilding an “integrative support stack”: nutrition, juicing, supplements, IV vitamin C, and lifestyleThe importance of organization and implementation: turning information into a workable scheduleNon-toxic living and environmental control (EMFs, chemicals, lighting, plastics, circadian rhythm)Mindset as medicine: trauma work, belief systems, meditation/breathwork, and daily centering practices“Cake vs. frosting”: foundational habits vs. advanced/experimental therapiesRyan's “talent scout” approach: finding top integrative cancer doctors and filtering conflicting infoGIP+ as a model for weekly expert access, Q&A, and a searchable archive of integrative guidanceTo learn more about Ryan and Teddy's work, explore The Stern Method, their step-by-step framework for implementing integrative cancer support in real life, at https://thesternmethod.com/ Listeners can also check out OUR 7, their comprehensive epigenetic nutrient blend from Our Health Naturally, available at https://ourhealthnaturally.com/ use the discount code KARLFELDT20 to receive 20% off from December 16–31, 2025, and KARLFELDT for 10% off ongoing orders after that.For those seeking direct access to top integrative cancer doctors, weekly guidance, and a searchable archive of expert insights, join Going Integrative Plus (GIP+) at https://goingintegrativeplus.com/and use the code KARLFELDT50 for 50% off your first month subscription. -----------------------------------------------A Better Way to Treat Cancer: A Comprehensive Guide to Understanding, Preventing and Most Effectively Treating Our Biggest Health ThreatGrab my book here: https://www.amazon.com/dp/B0CM1KKD9X?ref_=pe_3052080_397514860 Unleashing 10X Power: A Revolutionary Approach to Conquering CancerGet it here: https://store.thekarlfeldtcenter.com/products/unleashing-10x-powerPrice: $24.99100% Off Discount Code: CANCERPODCAST1 Healing Within: Unraveling the Emotional Roots of CancerGet it here: https://store.thekarlfeldtcenter.com/products/healing-withinPrice: $24.99100% Off Discount Code: CANCERPODCAST2-----------------------------------------------Integrative Cancer Solutions was created to instill hope and empowerment. Other people have been where you are right now and have already done the research for you. Listen to their stories and journeys and apply what they learned to achieve similar outcomes as they have, cancer remission and an even more fullness of life than before the diagnosis. Guests will discuss what therapies, supplements, and practitioners they relied on to beat cancer. Once diagnosed, time is of the essence. This podcast will dramatically reduce your learning curve as you search for your own solution to cancer. To learn more about the cutting-edge integrative cancer therapies Dr. Karlfeldt offer at his center, please visit www.TheKarlfeldtCenter.com

Game Over: c*ncer really lives up to its name in this one. In this special episode, we celebrate 10 years of impact with the very first researcher Cannonball Kids' cancer Foundation (CKc) ever funded, Dr. Ted Johnson.Dr. Johnson is a professor of pediatric oncology and co-director of the Pediatric Immunotherapy Program at Augusta University, a destination program for children with brain cancer who have run out of standard options. Val Solomon and Dana Nichols sit down with him to talk about how one early CKc grant helped launch a decade of progress in pediatric brain cancer immunotherapy, from saving and studying monthly blood samples to building a powerful biological sample bank that is now changing what is possible for kids.You will hear how a “leap of faith” investment became the spark behind clinical trials that have now provided experimental immunotherapy to more than 270 children and young adults from over 30 states. Dr. Johnson explains how indoximod-based immunotherapy works, why activating a child's immune system is so rare and so important, and how small donations, bake sales, and grassroots philanthropy truly keep this work alive.The conversation also pulls back the curtain on CKc's Scientific Advisory Board, why it was built to push research out of the lab and into the clinic, and how that original vision has grown into a Zoom screen full of experts carefully reviewing targeted grants that directly impact kids and families. Dr. Johnson shares what he is seeing on the NIH Review Board, why pediatric grants are still outnumbered by adult oncology proposals, and what this means for the future of funding and innovation in childhood cancer.If you have ever wondered whether your $50 or $100 really matters, this episode is for you. You will hear exactly how early seed funding, focused clinical trial grants, and community support create a snowball effect that leads to new therapies, better outcomes, and real hope for children with brain cancer.Learn more about the grants we fund, our Scientific Advisory Board, and how to make a gift at: cannonballkidscancer.orgIf this conversation encourages you, please like this video, subscribe to the Game Over: c*ncer Podcast, and share it with someone who cares about changing the future for kids with cancer.Together, we can transform fear and fuel the next decade of breakthroughs.----------------------------------Connect with Dana: https://www.linkedin.com/in/danaknichols/Connect with Val: https://www.linkedin.com/in/valerie-solomon/Upcoming Ckc Events: https://cannonballkidscancer.org/category/make-an-impact/events/----------------------------------Podcast Produced by Hi Hello Labs: Website: https://www.hihellolabs.com/

In this powerful episode of Keeping Abreast, Dr. Jenn Simmons sits down with Ryan Sternagel, founder of The Stern Method, to share the story that reshaped his life: his son's cancer diagnosis and the desperate search for answers that followed. What began as a parent's nightmare became a deep dive into integrative medicine, environmental toxicity, nutrition, and the healing power of community.Ryan opens up about navigating a rigid medical system, facing pressure from institutions, and refusing to ignore his intuition. He and Dr. Jenn explore what happens when families question conventional recommendations, how holistic therapies can support traditional treatment, and why creating a healing environment is essential.This is a conversation about resilience, advocacy, and the belief that healing requires more than protocols. It's about parents becoming empowered, finding the right team, and discovering hope in the darkest moments.In This Episode, You Will Learn:How Ryan's son's diagnosis launched his mission in integrative healthThe challenges families face when questioning conventional treatmentWhy intuition and research matter in medical decision makingHow nutrition and alternative therapies support cancer careThe emotional and practical realities of navigating the systemThe importance of community, mindset, and family supportWhy no single therapy is ever a silver bulletHow environment and lifestyle shape healingThe role of supplements within a comprehensive planWhat it means to build a truly healing home

In this episode of the Gladden Longevity Podcast, Dr. Jeffrey Gladden interviews Vlad Vukicevic , CEO and founder of the Better & Better, who shares his remarkable journey from childhood cancer survivor to entrepreneur in the health and wellness space. The conversation explores themes of longevity, health challenges, mental health, and innovative health products, emphasizing the importance of preventive care and personal growth.   For Audience ·       Use code 'Podcast10' to get 10% OFF on any of our supplements at https://gladdenlongevityshop.com/ !      Takeaways ·       Vlad's journey began with a cancer diagnosis at age five. ·       He underwent extensive treatment, including chemotherapy and a bone marrow transplant. ·       The experience shaped his understanding of mortality and health. ·       Vlad's family provided crucial support during his health challenges. ·       He developed a hypochondriac tendency due to his past health issues. ·       Vlad emphasizes the importance of ongoing health monitoring. ·       He founded Better and Better to innovate in health products. ·       The company focuses on integrating health benefits into everyday routines. ·       Vlad believes in continuous improvement in health and wellness. ·       He aims to make health management easier for everyone.     Chapters 00:00 Introduction to Longevity and Health 01:34 Vladimir's Early Health Challenges 04:43 The Impact of Childhood Cancer 09:06 Coping with Mortality and Mental Health 13:42 Navigating Teenage Years Post-Cancer 17:16 Ongoing Health Monitoring and Preventive Care 19:59 The Evolution of Health Awareness 22:46 Entrepreneurial Journey and Health Innovations 27:24 The Future of Health Products 32:00 Conclusion and Personal Growth   To learn more about Vlad: Website: https://www.betterandbetter.com/   Reach out to us at:    Website: https://gladdenlongevity.com/     Facebook: https://www.facebook.com/Gladdenlongevity/    Instagram: https://www.instagram.com/gladdenlongevity/?hl=en     LinkedIn: https://www.linkedin.com/company/gladdenlongevity    YouTube: https://www.youtube.com/channel/UC5_q8nexY4K5ilgFnKm7naw   Gladden Longevity Podcast Disclosures Production & Independence The Gladden Longevity Podcast and Age Hackers are produced by Gladden Longevity Podcast, which operates independently from Dr. Jeffrey Gladden's clinical practice and research at Gladden Longevity in Irving, Texas. Dr. Gladden may serve as a founder, advisor, or investor in select health, wellness, or longevity-related ventures. These may occasionally be referenced in podcast discussions when relevant to educational topics. Any such mentions are for informational purposes only and do not constitute endorsements. Medical Disclaimer The Gladden Longevity Podcast is intended for educational and informational purposes only. It does not constitute the practice of medicine, nursing, or other professional healthcare services — including the giving of medical advice — and no doctor–patient relationship is formed through this podcast or its associated content. The information shared on this podcast, including opinions, research discussions, and referenced materials, is not intended to replace or serve as a substitute for professional medical advice, diagnosis, or treatment. Listeners should not disregard or delay seeking medical advice for any condition they may have. Always seek the guidance of a qualified healthcare professional regarding any questions or concerns about your health, medical conditions, or treatment options. Use of information from this podcast and any linked materials is at the listener's own risk. Podcast Guest Disclosures Guests on the Gladden Longevity Podcast may hold financial interests, advisory roles, or ownership stakes in companies, products, or services discussed during their appearance. The views expressed by guests are their own and do not necessarily reflect the opinions or positions of Gladden Longevity, Dr. Jeffrey Gladden, or the production team. Sponsorships & Affiliate Disclosures To support the creation of high-quality educational content, the Gladden Longevity Podcast may include paid sponsorships or affiliate partnerships. Any such partnerships will be clearly identified during episodes or noted in the accompanying show notes. We may receive compensation through affiliate links or sponsorship agreements when products or services are mentioned on the show. However, these partnerships do not influence the opinions, recommendations, or clinical integrity of the information presented. Additional Note on Content Integrity All content is carefully curated to align with our mission of promoting science-based, ethical, and responsible approaches to health, wellness, and longevity. We strive to maintain the highest standards of transparency and educational value in all our communications.

Join host Dr. Mario Espinoza-Kulick for a conversation with leaders from End Kids Cancer, a San Luis Obispo–based organization working at the forefront of pediatric cancer research, family navigation, and prevention. Listen and participate live Thursdays from 1-2pm on KCBX

Guest Dr. Rusha Bhandari and host Dr. Davide Soldato discuss JCO article "Health Outcomes Beyond Age 50 Years in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study, " with a particular focus on mortality data, development of secondary malignancies and the importance of education for both patients and healthcare providers regarding long-term follow-up and care. TRANSCRIPT The guest on this podcast episode has no disclosures to declare. Dr. Davide Soldato: Hello, and welcome to JCO After Hours, the podcast where we sit down with authors from some of the latest articles published in the Journal of Clinical Oncology. I am your host, Dr. Davide Soldato, Medical Oncologist at Ospedale Policlinico San Martino in Genoa, Italy. Today, we are joined by JCO author, Dr. Rusha Bhandari, a Pediatric Hematologist-Oncologist and Assistant Professor in the Department of Pediatrics and Population Science at City of Hope, California. Today, we will be discussing the article titled "Health Outcomes Beyond Age 50 Years in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study." So, thank you for speaking with us, Dr. Bhandari. Dr. Rusha Bhandari: Thanks so much for having me. Dr. Davide Soldato: So, I just want to go straight ahead in the paper and start from the title. So, we heard that you included in this study childhood survivors of pediatric cancer that were aged 50 years or higher. So, this is a very critical life stage when we know that there are a lot of aging-related comorbidities that can happen, also in the general population but potentially specifically in childhood cancer survivors. So, first of all, I wanted to ask you, why this specific study in this very specific population? Because I think that we had already some data in younger survivors, but now we are focusing specifically on patients aged 50 or more. Dr. Rusha Bhandari: Absolutely. So, to answer that question, I'll take a little bit of a step back in terms of where we are now and where we came from in terms of treatment for childhood cancers. So, thankfully, we now have great curative therapies and survival rates for many childhood cancers, including the most common ones. But this was not necessarily the case 50 or more years ago. So, we essentially are now seeing the first generation of older survivors who are 30, 40, or more years from completion of their cancer treatment. As you pointed out, we know from younger survivors that they have a markedly higher risk of malignancies and health conditions than the general population. You don't typically expect to see things like heart disease or diabetes, for example, in a young adult. But the question that remained was what the health status and risk of these conditions are in survivors who are entering this critical age, as you mentioned, 50 or older, when you do start to see these aging-related changes in the general population. And the question is whether we're still observing increased risks related to cancer treatment that was delivered 30 or more years ago in these survivors who are now entering ages 50 and beyond. Dr. Davide Soldato: Thanks so much. You used the data from a study that is called the Childhood Cancer Survivor Study. So, just a little bit of explanation for our listeners. How is the study conducted? What type of data are you collecting? And specifically for the interest of the study that was reported in this manuscript, which outcomes were really important for you and were so evaluated in the manuscript? Dr. Rusha Bhandari: Yes. So, the Childhood Cancer Survivor Study is a really excellent resource that combines information from children who were treated across North America at various different centers and sites. So it gives us a really good understanding of how different survivors are doing as they do progress through their survivorship journey. The Childhood Cancer Survivor Study includes a baseline questionnaire when participants are first eligible or first enter the study, and then includes a series of follow-up questionnaires to really understand how they're doing, like I mentioned, as they progress throughout their survivorship journey. And so for this study, we really wanted to take a global look at how these patients were doing as they entered that older age range. And so we wanted to look at outcomes ranging from mortality through the health conditions that we've seen from other survivorship studies, including subsequent malignant neoplasms, other health conditions, I mentioned earlier heart disease and other comorbidities we know survivors can be at increased risk for, and also things like frailty, which we know is, you know, the most widely recognized phenotype of aging. And we see that earlier on in our younger survivors. We want to see how this translated to these older survivors and then also other health outcomes like their health status. What is their self-report of their physical health, their mental health? Things like that. So we wanted a very comprehensive understanding of their health. Dr. Davide Soldato: This is a very comprehensive study. Right now it includes more than 30,000 patients that have been treated for childhood cancer, but specifically looking at the question of survivors aged 50 years or higher, you included more than 7,000 patients inside of this study. So, looking at the first outcome that you mentioned, which I think it's also one of the most important, you look specifically at mortality, and in this specific population, you saw a striking three-fold increase in mortality when comparing these survivors with the general population. I just wanted to dive in this result and ask you: What do you see as the main driver for this excess mortality in this population of survivors? And as you were mentioning, the study also collects information about the treatment received. So, was there any association with a specific kind of treatment that was received for curing these childhood cancers? Dr. Rusha Bhandari: I agree. I would say it's striking to see that mortality risk among the survivors relative to the general population. And we do know, again from prior studies, that survivors of childhood cancer do have an increased risk of mortality compared to the general population, but I think looking at those curves of the cumulative mortality risk was really quite striking as they diverge, and that's, you know, just so long past their initial diagnosis and treatment. We know that subsequent malignant neoplasms or secondary cancers are a really an important contributor to mortality among survivors. And I think it was important to note that even in these older survivors, it's still such an important contributor to mortality, and I think this really highlights the need for us to better understand what is driving specific secondary cancers and what are the differences in the biology and treatment approaches for some of these cancers? And how might that then be contributing to the mortality risk? Dr. Davide Soldato: Related to the treatment mortalities - because I think that one of the main forces of the study, as it is conducted, is that it contains a lot of information regarding radiotherapy, allogeneic transplant, surgery, type of chemotherapy received by these survivors - so, are we able right now with the data that we have to pinpoint which of these treatments can potentially lead to such increased risk of mortality? Dr. Rusha Bhandari: So, we weren't able to look at the comprehensive treatment exposures and mortality risk for this paper. So that might be one of the questions I would put on the side. We were able to look at that in relation to subsequent malignant neoplasms and health conditions though, as you mentioned. Dr. Davide Soldato: Another thing that I think is very important is that you were able to look at specific causes for mortality. So for example, you mentioned the increased rate of neoplasm in this population and specifically, more or less 7.6% of the patients that were included in the study developed another neoplasm after the ones they were cured for in the childhood period. So, you saw a wide range of cancer, for example, bone and soft tissue sarcomas, breast cancer, genitourinary cancer. And as you were mentioning, there were some associations for treatment modalities that were associated with a higher risk of developing this type of cancer. Can you expand a little bit on this? Dr. Rusha Bhandari: Absolutely. And so the key part here was that we really looked at any of these outcomes that occurred beyond age 50. What we found was there is still an increased risk of secondary cancers beyond that initial childhood cancer diagnosis, but when we really looked at that data, it was specifically among survivors who had a history of receiving radiation. And we did not necessarily see an association between different chemotherapy exposures and secondary cancers. And I think this speaks to what we're now learning in terms of the very long-term effects of radiation and how that impacts ongoing health risk even in patients who are 30 or more years out from their treatment. And I think it really highlights the importance of these- the efforts that have been made in the more recent decades to really try and reduce or eliminate radiation where possible, you know, as we've come to understand more about these long-term effects from it. Dr. Davide Soldato: A clear association with radiation therapy but no association when we look at specific types of chemotherapy that were used for curing this childhood cancer. Another thing that I think it's very interesting and you briefly mentioned before is that potentially when we look at these secondary malignant neoplasm that develop in this situation, we might also see some outcomes that are not comparable to the one of the general population, meaning that we managed to cure less this type of cancer when they develop in these childhood survivors. So, I just wanted to understand if you could provide us with a little bit of perspective also from a clinical standpoint being a pediatric hematologist-oncologist as to why this might be happening and how can we potentially increase the cure rate also in this population of childhood cancer survivors? Dr. Rusha Bhandari: Absolutely. While that was not the focus of this study, it was something that we were certainly interested in is understanding how even once a childhood cancer survivor, for example, develops a health condition or a secondary cancer further into survivorship, how does that outcome then differ from someone in the general population? And there's a lot of interest in ongoing studies actually evaluating that and understanding what are the differences from the initial presentation, biology, the characteristics of that cancer, through how they're treated. So I don't know if we have all of the answers for that quite yet, but you can imagine if someone hypothetically had a history of receiving a lot of anthracycline chemotherapy or already having received a lot of radiation, that might impact what treatment they might receive for that secondary cancer or if they already have other existing comorbidities that need to be taken into consideration. Dr. Davide Soldato: Speaking about comorbidities, you were mentioning in the beginning that one of the focuses of this scientific work was really to try and see whether also this type of adverse health outcomes that can be potentially related to treatments were more frequent among these childhood cancer survivors. So I think that it's very interesting that for this comparison, you were able to use the data from the siblings of the patients who were included inside of the study. So, just a little bit of a comment on why you decided to use this specific methodology, which I think has a very nice touch to it when we look at these outcomes like, for example, diabetes or cardiovascular disease, and in general, do we see an increased number of chronic health conditions among survivors who were treated for childhood cancers? Dr. Rusha Bhandari: Yes, so this is a really excellent strength of the Childhood Cancer Survivor Study is that they have information, longitudinal information, on survivors as well as their siblings. So, you know, when we were discussing the design of the study, I mentioned that we have initial baseline questionnaires as well as multiple follow-up questionnaires, and that is for both the survivors and the siblings. And so we're able to really understand their health course over time. We chose to evaluate sibling data because then you're really able to look at people who have similar characteristics, right? Similar environmental exposures in theory, potentially similar genetic predispositions and makeups and things like that. And so you can really try and have as good of a comparison as possible. Dr. Davide Soldato: Did we see any increase in chronic health condition when looking at survivors compared to the siblings? Dr. Rusha Bhandari: We did. And while that's been reported before, again, I think it's important to demonstrate that in this older population when you would expect that these siblings would now also be starting to develop different health conditions. Dr. Davide Soldato: One thing that was very interesting is that when we look at the coexistence of multiple comorbid conditions and chronic condition in this population, we also see that for some of these survivors, they basically have the same rates of comorbidities as compared to siblings who are potentially 20 years older than them. So I think that there is really that striking point, as you were mentioning before, of accumulation of changes, also physiological changes that can potentially drive a higher frailty index, which was also higher when looking at these survivors compared to their siblings. One outcome that was really not that worse when we look at survivors of childhood cancer was actually mental health. And as I read the paper, it was something that really surprised me a little bit because you would imagine that going through such a harsh diagnosis, such very complex treatment, very early in their life could potentially lead to some worse health outcomes also in terms of mental health over time. But this was not seen. And just a comment on this, because I think it's a very surprising data. Dr. Rusha Bhandari: Yes, I appreciate that question. So, as you mentioned, mental health is such an important issue for patients, both those undergoing treatment as well as those in long-term survivorship. And in our study, we found that survivors were not more likely, as you mentioned, to report poor mental health compared to their siblings. And I think there's a few possible reasons for this. You know, again, this is self-reported data amongst siblings and survivors who survived to at least 50 years of age and completed a questionnaire. And so that is the group of individuals that we were able to evaluate this in, so we have to keep that in mind. But I think our findings may also reflect the resilience of this particular cohort of aging survivors that we included. This finding has been reported in other studies of survivors as well, and so I think it very well may speak to the resilience of the cohort that we're looking at. Dr. Davide Soldato: Going back just a little bit, you mentioned that the majority potentially of these survivors who were included in the current analysis were treated between 1970s and 1980s. So, as you were mentioning before, radiotherapy was seen as a significant contributor to second neoplasm and also to the increase of this chronic health condition. So, do you believe that there is still a role for these survivorship studies as we are approaching treatment modalities where radiotherapy is administered less frequently or with lower doses or omitted at all in the treatment course of these survivors? Dr. Rusha Bhandari: Absolutely. I think you mentioned a very important point, which is these findings are most applicable to the patients who were included in this cohort or similar cohorts, those who were treated in the 1970s and 80s who now are 50 years or older at this point in time. And as you know, treatment modalities have really changed. You know, as you mentioned, we'll use less radiation in many cases whenever possible, but there are so many new modalities, so many different chemotherapeutic agents, immunotherapy. There's so much more we need to learn about the long-term effects of some of these newer treatment modalities. And also, we've been able to really intensify our treatment regimens with improvements in both treatment approaches and supportive care. And so I think we have a lot to learn about those late effects, and ongoing studies are certainly needed as we continue to have this growing population of older survivors. Dr. Davide Soldato: And now a more general question which builds on the results of the study but goes a little bit beyond what was the scope of the research. So we have just discussed that there is an excess mortality in general, there is a higher risk for secondary malignancies in this population, we see higher accumulation of chronic comorbid conditions that need to be treated. So building on these results, in your opinion, what would be the best framework to follow up these patients over time? Because I imagine that for some of these patients who have been treated 30, 40 years before the moment where we see this type of events, they can be potentially also discharged from more specialistic medical care. So what is the best course of action? Should we keep all of these patients under observation in a very specialistic environment under the care of the oncologist or the pediatric oncologist? Should we create a stronger bond with general practitioners so they know that there is this problem? Dr. Rusha Bhandari: Yes, I mean, I think you're reading my mind. We thankfully do have evidence-based guidelines. We utilize the Children's Oncology Group Long-Term Follow-Up Guidelines, which include screening recommendations for secondary cancers, chronic health conditions, everything based on the underlying diagnosis and treatment that these patients received. But we recognize that a large proportion of these survivors do not continue to have lifelong follow-up at a survivorship center, but really do need that specialized screening based on their treatment that they received. And I think for that reason, it's so important that we continue to build relationships with their primary care providers and really make sure that both patients and their providers have this information at hand regarding what their treatment is and what the screening is that they need and that we be able to have this community whereby we are able to help inform the screening in our own survivorship clinics, but also help guide some of the primary care providers who are going to be seeing these patients in the long run. Dr. Davide Soldato: Do we have any data showing what is the adherence rate of these patients to this type of continuous screening and monitoring over time? Because I imagine that that might also be a point for improvement in terms of quality of care. Can we retain as much childhood cancer survivors as we want as we are learning that there are all these potential negative health outcomes over time? Dr. Rusha Bhandari: We definitely within the survivorship community do want to help make sure as many survivors as possible are being engaged, again, whether it's at their specific cancer center or whether it's in the community, recognizing that for many reasons, it's not feasible to always return to that cancer center for your regular survivorship care. I think there's a lot we can do. Going a little bit outside the scope of your question, but I think there's a lot that we can do nowadays in terms of telehealth and being able to communicate with patients and their providers even if they're geographically not located right near us. But we do have data that shows that the further out many patients get from their initial diagnosis and treatment, the less often they might follow up with a survivorship provider. Some of this varies by different treatment. Dr. Davide Soldato: So, basically the final question is that we need more education and potentially more resources for survivorship clinics and in general to better inform patients and providers about these potential long-term outcomes. Dr. Rusha Bhandari: That's certainly a focus of our survivorship program, for example, is to make sure that we're able to educate patients, inform them of their risks, and why certain screening tests are recommended at certain times in their survivorship journey. And then I think again, thankfully nowadays with all of the electronic medical records and different methods for us to communicate, there's a lot of opportunity for us to continue building these relationships with those primary care providers and making sure they have the information at their fingertips as well as to be able to work in conjunction with these patients to continue to formulate their plans and carry out these screenings and then again, like I was saying, have an easy open line of communication with the oncology centers if they do have any questions. Dr. Davide Soldato: Thanks so much. This brings us to the end of this episode. I would like to thank again Dr. Bhandari for joining us today. Dr. Rusha Bhandari: Thank you so much. It's been a real pleasure speaking with you. Dr. Davide Soldato: And we appreciate you sharing more on your JCO article titled "Health Outcomes Beyond Age 50 Years in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study." If you enjoy our show, please leave us a rating and review and be sure to come back for another episode. You can find all ASCO shows at asco.org/podcasts. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.  

In episode 96 of the Summits Podcast, co-hosts Vince Todd, Jr. and Daniel Abdallah are joined by Dr. Robyn Spoon, CEO of Elevate Childhood Cancer Research and Advocacy. Tune in as Robyn shares her son's cancer story that ignited a passion for change and how Elevate Childhood Cancer Research and Advocacy is moving the needle on precision medicine for those diagnosed with childhood cancer. Learn more about Elevate Childhood Cancer Research and Advocacy at elevatechildhoodcancer.org. The Heroes Foundation Team JOEY Program proudly sponsored the 2nd Annual Indiana Pediatric Sarcoma Research & Advocacy Summit. Together, we will continue uniting Indiana against cancer.

Alex Conley has lived every phase of the wellness journey, from surviving childhood cancer to chasing fitness perfection to realizing that health isn't something you buy, it's something you build through integrity and awareness. In this episode, Alex shares how years in the fitness and supplement industries exposed the cracks in our modern health system — from FDA loopholes and overprocessed supplements to the corruption of Big Food and the destruction of our soil. He explains why simplicity is the real cure, what we get wrong about hydration, and how mental health, anger, and anxiety are symptoms of a deeper imbalance in the way we live. We also cover: Why only 12% of second opinions confirm the original diagnosis How the supplement industry gets away with harmful ingredients What 98% of conventional farming means for your health The connection between soil quality, nutrition, and mental well-being Why the cure has always been simple — and how to return to it This conversation will challenge what you think you know about “wellness” and remind you that healing doesn't have to be complicated. Resources: → CURED | Right now, CURED Nutrition is offering my listeners an exclusive 20% off ON TOP OF the 10% off Best Seller Bundle. Just head to https://www.curednutrition.com/CLAUDIA and use the code CLAUDIA at checkout → PUORI | Shop Puori grass-fed protein powder + supplements (Clean Label Certified and third-party tested!!!) Use discount code: HEALINGTHESOURCE Follow Alex on Instagram Check out KONO's website for holistically formulated supplements. Discount code: HEALING Follow the host, Claudia, on Instagram, check out HealingTheSource.co & Elham's Liquid Gold 100% Organic Castor Oil, and enjoy her deep-dives on Substack

In this powerful episode of the Game Over: c*ncer, hosts Dana and Val sit down with Maria Ochoa, president and co-founder of Mia's Miracles Foundation. Maria, along with her husband, professional golfer Camilo Villegas, created Mia's Miracles in honor of their daughter Mia, who passed away from brain and spine cancer at just 22 months old.Maria opens up about surrender, grief, PTSD, and the unseen weight caregivers carry. She shares how love, boundaries, and support can transform the hardest seasons. She shares Mia's story, the impact of treatment on the family, and why caregiver well-being is essential to a child's care. Maria also discusses her own recent health battles, the choices she made, and the peace she's found on the other side, offering wisdom for anyone navigating fear, trauma, or loss.In this episode we explore:The reality of pediatric cancer for the whole family, and why caregiver health mattersGrief, fear, and PTSD: naming it, facing it, and finding tools to healBoundaries, marriage, and moving through hard things togetherThe mission and impact of Mia's Miracles Foundation Practical ways anyone can help, because small gifts add up to big changeConnect with our guest and learn about and support Mia's Miracles Foundation at:mias-miracles.orgIf this conversation moves you, please like, comment, and share to help us educate for change. Leaving a review helps more families find tangible hope.Tune in to hear this inspiring and informative conversation. Don't forget to subscribe, leave a review, and join the fight to make Game Over: c*ncer a reality.Connect with Dana: https://www.linkedin.com/in/danaknichols/Connect with Val: https://www.linkedin.com/in/valerie-solomon/Upcoming Ckc Events: https://cannonballkidscancer.org/category/make-an-impact/events/----------------------------------Podcast Produced by Hi Hello Labs: Website: https://www.hihellolabs.com/

Dr. Uri Tabori is a Staff Physician in the Division of Haematology/Oncology, Senior Scientist in the Genetics & Genome Biology program, and Principal Investigator of The Arthur and Sonia Labatt Brain Tumour Research Centre at The Hospital for Sick Children (SickKids). Uri is also a Professor in Paediatrics and Associate Professor in the Institute of Medical Sciences at the University of Toronto. Uri works as a physician treating kids with cancer, particularly brain tumors. Through his research, he is working to identify drugs and make new discoveries that may cure cancers or improve patients' lives. When he's not hard at work in the lab or clinic, Uri enjoys spending time with his family, watching American football, and exploring the wilderness of Canada. He is especially fond of canoeing and canoe camping with his family. He received his MD from the Hadassah School of Medicine of Hebrew University in Israel. Afterwards, he completed a Rotating Internship and his Residency in Pediatrics at the Sorasky Medical Center in Israel. Next, Uri accepted a Fellowship in Pediatric Hematology and Oncology at the Sheba Medical Center in Israel. He served as a Staff Physician in Pediatric Hematology and Oncology at The Sheba Medical Center for about a year before accepting a Research and Clinical Fellowship at The Hospital for Sick Children in Canada SickKids where he remains today. Over the course of his career, Uri has received numerous awards and honors, including the Early Researcher Award from the Ontario Ministry of Development and Innovation, the New Investigator Award from the Canadian Institute of Health Research, the Junior Physician Research Award from the University of Toronto Department of Pediatrics, The New Investigator Award from the Terry Fox Foundation, A Eureka! new investigator award from the International Course of Translational Medicine, A Merit Award from the American Society of Clinical Oncology Annual Meeting, and The Young Investigator Award from the Canadian Neuro-Oncology Society. In our interview, Uri shares more about his life, science, and clinical care.

The Rich Zeoli Show- Hour 2: 4:00pm- Brent Sadler—Senior Research Fellow for Naval Warfare and Advanced Technology in the Allison Center for National Security at The Heritage Foundation—joins The Rich Zeoli Show to break down Secretary of War Pete Hegseth's new combat directives to senior military officials. During a speech from Quantico, Virginia earlier today, Hegseth memorably declared: “Simply put, if you do not meet the male level physical standards for a combat position, cannot pass a PT test, or don't want to shave and look professional—it's time for a new position.” 4:30pm- From the Oval Office, President Donald Trump signed executive orders lowering the cost of pharmaceuticals and vowing to use technological innovations, like artificial intelligence, as well as increased federal funding to defeat childhood cancer. 4:40pm- While speaking with the press, President Donald Trump said the U.S. is likely to experience a government shutdown at midnight on Tuesday—noting that Democrats won't agree on a continuing resolution (CR) and are demanding government-provided healthcare for migrants residing in the country illegally. President Trump said if Democrats remain unreasonable, he will use the shutdown to make permanent cuts to the federal workforce.

Kristin Connor was living a typical life as a business litigation attorney, a job she held for about a decade and absolutely loved. Then, while she was pregnant with her second child, everything changed. Her unborn son was diagnosed with an unusual form of neuroblastoma, a cancer that's rare in children to begin with, and almost unheard of in unborn babies. After he was born, Kristin and her family spent two years going through test after test, tracking the tumor and evaluating options – all before any invasive surgery ever occurred. After trekking 3,000 miles, clear across the country, to meet with a doctor who seemed to offer the least worst alternative, the hand of god stepped in a performed what can only be described as an honest-to-goodness miracle. More on that in the interview. This experience led Kristin to leave her law career behind and dedicate her life to helping other families whose children are battling cancer. Today, Kristin is the CEO of CURE Childhood Cancer, a national nonprofit organization that raises millions of dollars each year to fund childhood cancer research and help families. September is Childhood Cancer Awareness Month, and your donations are encouraged today and every day. You can donate directly at THIS LINK. In this inspiring episode, Kristin shares more about what she loved as an attorney; the way she got involved in childhood cancer research; how she became totally disillusioned with the other cancer nonprofit organizations out there; what Major League Baseball Hall of Fame pitcher Tom Glavine and then-Commissioner Bud Selig had to do with it; why she does what she does today; and of course, the miracle she experienced. Again, please donate to Kristin's organization, CURE Childhood Cancer, at THIS LINK. No amount is too small, and every penny brings them one penny closer to saving a life. ******* If you enjoy Second Act Stories, please leave us a review here. We may read your review on a future episode! Subscribe to the Second Act stories Substack. Check out the Second Act Stories YouTube channel. Follow Second Act Stories on social media: Facebook LinkedIn Instagram Second Act Stories theme music: "Between 1 and 3 am" by Echoes.

Super Bowl-winning coach Tom Coughlin turns his focus to food insecurity in families dealing with childhood cancers.

The episode explores what SLPs need to know about childhood cancer. Its goal is to function as a broad introduction to this topic, primarily for SLPs who work in educational settings. The episode begins with some childhood cancer basics, including the most common types of pediatric cancers, as well as an overview of childhood cancer symptoms. The episode then examines the different ways in which childhood cancer can impact different facets of communication, including articulation, cognition, language, voice, hearing, and swallowing. The episode emphasizes the importance of collaboration when working with this population, and closes with a reminder that SLPs from educational settings have valuable support to offer children and families who have been impacted by cancer.

In this heartfelt episode of Kankakee Podcast, Drew sits down with Brady and Joy, a couple who moved their family of nine to Kankakee just two years ago. What began as a season of new beginnings quickly turned into a life-altering journey when their youngest daughter, Eloise, was diagnosed with leukemia at just three years old.Brady and Joy open up about the shock of the diagnosis, the chaos of moving while balancing hospital visits, and the strength they found in their faith, community, and each other. From Eloise's battle through treatment to the powerful moment she rang the bell and became cancer-free, this is a story of resilience, hope, and the power of community love.Send us a text Support the show

August 29, 2025: Michael Robinson, VP of Healthcare Solutions (Americas) from Omnissa, discusses what it takes to maintain momentum during massive transitions and Omnissa's vision for autonomous workspaces. As healthcare organizations face shrinking margins and accelerating digital demands, Michael explores how strategic partnerships with Epic and CrowdStrike are reshaping the technology landscape. With the upcoming Omnissa One summit featuring a dedicated healthcare track, the conversation touches on emerging trends beyond AI—from IoT in medical devices to virtual hospitals—while examining how technology companies can genuinely align with healthcare's evolving priorities in an increasingly complex market. Register now to join Omnissa at Omnissa ONE: Learn more at Omnissa.com. Key Points: 00:54 Omnissa's Journey and Vision 05:17 Omnissa One Summit Details 08:36 Future Trends and Personal Insight X: This Week Health LinkedIn: This Week Health Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer

August 28, 2025: In this Keynote Rewind episode, we explore how organizations balance the revolutionary potential of generative AI with the critical need for rock-solid infrastructure. Leaders share stories of mobile clinics outperforming traditional facilities, drone deliveries reaching remote islands, and home-based care achieving superior outcomes to hospital stays. With TEFCA enabling secure data exchange across state lines and remote patient monitoring saving children's lives, what happens when healthcare finally has the framework to scale innovation?  Key Points: Taylor Davis - [00:01:00] Glen Tullman - [00:02:00] Doug King - [00:03:00] B.J. Moore - [00:04:00] Shakeeb Akhter - [00:05:00] Chad Brisendine - [00:06:00] Bradd Busick / Brent Lamm - [00:07:00] Tim Skeen / Andrew Rosenberg - [00:08:00] Mickey Tripathi - [00:09:00] Aneesh Chopra / Craig Richardville - [00:11:00] Christopher Longhurst - [00:12:00] and [00:14:00] Daniel Barchi - [00:12:00] Alistair Erskine - [00:12:00] and [00:14:00] Keith Perry - [00:13:00] Stephen Klasko - [00:14:00] X: This Week Health LinkedIn: This Week Health Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer

August 27, 2025: Dan Dodson, CEO of Fortified Health Security, discusses how healthcare organizations are rethinking cybersecurity strategy amid mounting financial pressures. Dan shares insights from their Nashville Executive Briefing Center, where healthcare leaders are uncovering critical gaps in their security programs. As AI tools spread faster than anyone anticipated—with physicians using platforms that security experts haven't even heard of—how do organizations balance innovation with control? With Medicare cuts looming and every cybersecurity dollar representing money moved away from patient care, are healthcare systems getting real value from their fragmented tool investments?  Key Points: 01:31 Executive Briefing Center Experience 06:27 Cyber Survivor Podcast 11:02 Midyear Horizon Report Insights 13:47 Lightning Round Questions X: This Week Health LinkedIn: This Week Health Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer

I have often said that different people grieve differently. Today's guest, Lori, adds a new twist to that statement. She lost two of her four sons almost 30 years apart from each other, and she is grieving so much differently now than she did the first time around, showing that the same person can grieve similar losses differently as well. The stories of Michael and Logan's deaths are far different. Michael died at age 2 of an aggressive type of cancer called neuroblastoma. He died after 9 months of treatment in his mother's arms at the hospital, which she says gave her time to say goodbye, but also forced her to watch him endure pain and suffering. Twenty-five-year-old Logan, on the other hand, died suddenly from an accidental drug overdose in his apartment. Logan was there one day and gone the next. Lori says that after losing Michael, she became an extremely compassionate person. She and her husband turned to each other for support. Loris describes him as her rock. She was very involved in church, turning to her faith to help ease the intense pain of loss. Over the years, Lori says that her biggest fear was that she might lose another one of her three remaining boys, but despite Logan's long history of mental health struggles, she did not ever think this would happen to them again. Then, 18 months ago, the unimaginable occurred - Logan died, too. After Michael died, compassion emerged. This time, however, fear and anger are the dominant emotions. She has trouble going out in public. Lori hasn't gone to church, and her faith feels broken. Her relationship with her husband has been damaged, and she has moved in with her two living sons, who are now her two rocks. Online support groups and podcasts have become her coping strategies.  These vastly different responses may seem surprising. I know they were unexpected to Lori, but there is a lesson here.  Grace. We need to give others and ourselves grace. We cannot control our feelings or our responses to grief. We need to feel our emotions, whatever they may be, and work through them. Through hard work, hope for the future may come again, for Lori and for us.

On this week's episode of The 1 Girl Revolution Podcast, we welcome Leia Hunt — cancer survivor, inspirational speaker, author, and founder of Leia's Kids - a nonprofit dedicated to supporting children and families battling cancer. Leia's own cancer journey began when she was just two years old, after being diagnosed with a rare form of eye cancer. She endured 26 surgeries and multiple rounds of chemotherapy, ultimately losing sight in one eye. But instead of letting her struggles define her, Leia turned her pain into purpose — speaking at the White House, working alongside the American Cancer Society and the Eye Tumor Research Foundation, and inspiring countless others through her story. At just 18 years old, while still in high school, Leia founded Leia's Kids — a nonprofit dedicated to supporting children and families battling childhood cancer. As a survivor herself, Leia knows firsthand the challenges these children and their families face. Her organization provides financial grants, hosts dream parties, organizes mental health retreats, and so much more — offering not just support, but joy, hope, and a sense of community during some of life's hardest moments. In this episode, you'll hear: ✨ Leia's incredible journey as a child with cancer and now as a cancer survivor; ✨ How her childhood experiences inspired her to start Leia's Kids at just 18; ✨ The heart and mission behind Leia's Kids — and the life-changing impact they have on families; ✨ Stories from the dream parties, retreats, and programs she's created; ✨ How faith and resilience have guided her through challenges; ✨ What she's learned about life, hope, and community from the children she serves; ✨ And so much more!